Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors
    • Author Guidelines
  • Content
    • Current Issue
    • Complete Issue PDF
    • Archive
    • 20th Anniversary Special Edition
    • Topic/Program Collections
    • Blog
    • Questions from NeoReviews
  • CME/MOC
    • CME Quizzes
    • MOC Claiming
    • NeoReviewsPlus
    • Board Review Study Guide
  • Multimedia
    • NeoReviews Video Library
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors
    • Author Guidelines
  • Content
    • Current Issue
    • Complete Issue PDF
    • Archive
    • 20th Anniversary Special Edition
    • Topic/Program Collections
    • Blog
    • Questions from NeoReviews
  • CME/MOC
    • CME Quizzes
    • MOC Claiming
    • NeoReviewsPlus
    • Board Review Study Guide
  • Multimedia
    • NeoReviews Video Library
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
American Academy of Pediatrics
Article

Growth and Development in Chronic Liver Disease

Norberto Rodriguez-Baez, Karen I. Wayman and Kenneth L. Cox
NeoReviews September 2001, 2 (9) e211-e214; DOI: https://doi.org/10.1542/neo.2-9-e211
Norberto Rodriguez-Baez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen I. Wayman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth L. Cox
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Comments
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Download PDF

Objectives

After completing this article, readers should be able to:

  1. Identify the two diseases emerging in the neonatal period that account for more than 50% of all pediatric liver transplantations completed each year.

  2. List the factors that affect growth in infants who have chronic liver disease.

  3. Delineate the factors affecting growth after liver transplantation.

  4. Identify factors that are associated with poor developmental outcome among children who undergo liver transplantation.

Introduction

Liver transplantation currently is the definitive therapy for various forms of end-stage liver disease in children. Each year, 400 to 600 children are diagnosed with a liver disease that requires transplantation. Such disease may be the result of metabolic (eg, alpha-1-antitrypsin deficiency), structural (eg, biliary atresia), obstructive (eg, hepatocellular disease), infectious (eg, hepatitis), or toxic (eg, drug overdose) causes. All of these conditions can progress to cirrhosis and end-stage liver disease. The incidence of neonatal liver disease is estimated as 1 in 2,500 live births. Two diseases emerging in the neonatal period account for 80% of the pediatric diagnoses: biliary atresia (50%) and neonatal hepatitis (30%). Consequently, children 1 year of age and younger account for approximately 50% of all pediatric transplantations completed in the United States each year (United Network for Organ Sharing, 2001).

Managing chronic liver disease in infants and children is a challenge because of the multiple complications that can result from the damaged liver. Among the complications of end-stage cirrhotic liver disease are growth failure and developmental deficits.

Growth Failure and Liver Disease

Failure to grow is a serious consequence of chronic liver disease that increases morbidity and mortality. A number of factors affect linear growth in infancy, including nutritional status, underlying liver diagnosis and alterations in the growth hormone (GH)/insulin-like growth factor (IGF)/insulin-like growth factor binding proteins (IGFBP) axis. The prevalence of malnutrition associated with chronic liver disease varies according to the …

Individual Login

Log in
You will be redirected to aap.org to login or to create your account.

Institutional Login

via Institution

You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.

Log in through your institution

If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

Offer Reprints

PreviousNext
Back to top

Advertising Disclaimer »

In this issue

NeoReviews: 2 (9)
NeoReviews
Vol. 2, Issue 9
1 Sep 2001
  • Table of Contents
  • Cover (PDF)
  • About the Cover
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Growth and Development in Chronic Liver Disease
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Growth and Development in Chronic Liver Disease
Norberto Rodriguez-Baez, Karen I. Wayman, Kenneth L. Cox
NeoReviews Sep 2001, 2 (9) e211-e214; DOI: 10.1542/neo.2-9-e211

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Growth and Development in Chronic Liver Disease
Norberto Rodriguez-Baez, Karen I. Wayman, Kenneth L. Cox
NeoReviews Sep 2001, 2 (9) e211-e214; DOI: 10.1542/neo.2-9-e211
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
    • Objectives
    • Introduction
    • Growth Failure and Liver Disease
    • Growth after Orthotopic Liver Transplantation (OLT)
    • Liver Disease and Child Development
    • Conclusion
    • Suggested Reading
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Comments

Related Articles

  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Craniosynostosis: Neonatal Perspectives
  • Congenital Hyperinsulinism
  • Revisiting Skeletal Dysplasias in the Newborn
Show more Articles

Similar Articles

Subjects

  • Gastroenterology
    • Hepatology
    • Gastroenterology
  • Journal Info
  • Editorial Board
  • Overview
  • Licensing Information
  • Authors/Reviewers
  • Author Guidelines
  • Submit My Manuscript
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • NeoReviewsPlus
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
  • NeoReviews™ and NeoReviewsPlus™ are supported, in part, through an educational grant from Abbott Nutrition, a division of Abbott Laboratories, Inc.
American Academy of Pediatrics

© 2021 American Academy of Pediatrics